- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2014
- Public Summary Document (PSD) July 2014 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2014 PBAC Meeting - Word
Rituximab – July 2014
RITUXIMAB, solution for IV infusion, 100 mg in 10 mL, 500 mg in 50 mL, MabThera®, Roche Products Pty Ltd
Last updated
8 November 2023